Agencja Oceny Technologii Medycznych i Taryfikacji (AOTMiT)
The Agency for Health Technology Assessment and Tariff System (AOTMiT) was established in 2005 as an advisory body to the Ministry of Health. Since 2009 AOTMiT is defined as a legal entity.
The main task of AOTMiT is the preparation for the Minister of Health recommendations on financing all health care services from public funds:
- Drug reimbursement list (available in pharmacy);
- Therapeutic drugs programs (high-cost, innovative drugs) and hospital’s chemotherapy drugs list;
- Non– drug technologies (medical devices, surgical procedures etc.);
- National and Local Government Health Care Programs.
The role of AOTMiT is to assess and appraise all medical technologies and services claiming public money founding. Recommendations, statements and opinions issued by AOTMiT are based on additional officially published data, experts opinions, Manufacturer`s submission and polish public payer (National Health Fund) evaluation.
Core activities of AOTMiT is also connected with producing health technology assessment (HTA) reports and collect, make available, and disseminate information on HTA results, methodologies, and recommendations generated within or outside of Poland.